Patrick Hranitzky to Aged
This is a "connection" page, showing publications Patrick Hranitzky has written about Aged.
Connection Strength
0.268
-
Williams ES, Shah SH, Piccini JP, Sun AY, Koontz JI, Al-Khatib SM, Hranitzky PM. Predictors of mortality in patients with chronic kidney disease and an implantable defibrillator: an EPGEN substudy. Europace. 2011 Dec; 13(12):1717-22.
Score: 0.035
-
Wallace TW, Atwater BD, Daubert JP, Voora D, Crowley AL, Bahnson TD, Hranitzky PM. Prevalence and clinical characteristics associated with left atrial appendage thrombus in fully anticoagulated patients undergoing catheter-directed atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2010 Aug 01; 21(8):849-52.
Score: 0.032
-
Gianni C, Horton RP, Nair G, La Fazia VM, Mohanty S, Al-Ahmad A, Allison JD, Bassiouny MA, Bode WD, Burkhardt JD, Chiricolo G, Gallinghouse GJ, Hranitzky PM, Sanchez JE, Nair DG, Natale A. Percutaneous Aspiration Thrombectomy in Patients With Persistent Left Atrial Appendage Thrombus: A Case Series. JACC Clin Electrophysiol. 2025 Nov; 11(11):2448-2457.
Score: 0.023
-
Di Biase L, Mohanty S, Trivedi C, Romero J, Natale V, Briceno D, Gadiyaram V, Couts L, Gianni C, Al-Ahmad A, Burkhardt JD, Gallinghouse GJ, Horton R, Hranitzky PM, Sanchez JE, Natale A. Stroke Risk in Patients With Atrial Fibrillation Undergoing Electrical Isolation of the Left Atrial Appendage. J Am Coll Cardiol. 2019 Aug 27; 74(8):1019-1028.
Score: 0.015
-
Gadiyaram VK, Mohanty S, Gianni C, Trivedi C, Al-Ahmad A, Burkhardt DJ, Gallinghouse JG, Hranitzky PM, Horton RP, Sanchez JE, Della Rocca DG, Di Biase L, Price MJ, Couts L, Gibson D, Natale A. Thromboembolic events and need for anticoagulation therapy following left atrial appendage occlusion in patients with electrical isolation of the appendage. J Cardiovasc Electrophysiol. 2019 Apr; 30(4):511-516.
Score: 0.015
-
Gianni C, Sanchez JE, Mohanty S, Trivedi C, Della Rocca DG, Al-Ahmad A, Burkhardt JD, Gallinghouse GJ, Hranitzky PM, Horton RP, Di Biase L, Natale A. Isolation of the superior vena cava from the right atrial posterior wall: a novel ablation approach. Europace. 2018 Sep 01; 20(9):e124-e132.
Score: 0.014
-
Mohanty S, Gianni C, Trivedi C, Metz T, Bai R, Al-Ahmad A, Bailey S, Burkhardt JD, Gallinghouse GJ, Horton R, Hranitzky PM, Sanchez JE, Di Biase L, Natale A. Impact of rotor ablation in non-paroxysmal AF patients: Findings from the per-protocol population of the OASIS trial at long-term follow-up. Am Heart J. 2018 Nov; 205:145-148.
Score: 0.014
-
Kim KH, Mohanty S, Mohanty P, Trivedi C, Morris EH, Santangeli P, Bai R, Al-Ahmad A, Burkhardt JD, Gallinghouse JG, Horton R, Sanchez JE, Bailey S, Hranitzky PM, Zagrodzky J, Kim SG, Di Biase L, Natale A. Prevalence of right atrial non-pulmonary vein triggers in atrial fibrillation patients treated with thyroid hormone replacement therapy. J Interv Card Electrophysiol. 2017 Aug; 49(2):111-117.
Score: 0.013
-
Gianni C, DI Biase L, Mohanty S, Trivedi C, Bai R, Al-Ahmad A, Burkhardt JD, Gallinghouse GJ, Horton RP, Sanchez JE, Hranitzky PM, Lakkireddy D, Mansour MC, Santangeli P, Zado ES, Marchlinski FE, Beheiry S, Hao SC, Couts L, Gibson D, Natale A. Management of Periprocedural and Early Pericardial Effusions With Tamponade Following Ablation of Atrial Fibrillation With Uninterrupted Factor Xa Inhibitors: A Case Series. J Cardiovasc Electrophysiol. 2016 Apr; 27(4):399-403.
Score: 0.012
-
Mohanty S, Mohanty P, Trivedi C, Gianni C, Bai R, Burkhardt JD, Gallinghouse JG, Horton R, Sanchez JE, Hranitzky PM, Al-Ahmad A, Bailey S, Di Biase L, Natale A. Association of pretreatment with angiotensin-converting enzyme inhibitors with improvement in ablation outcome in atrial fibrillation patients with low left ventricular ejection fraction. Heart Rhythm. 2015 Sep; 12(9):1963-71.
Score: 0.011
-
Mohanty S, Natale A, Mohanty P, DI Biase L, Trivedi C, Santangeli P, Bai R, Burkhardt JD, Gallinghouse GJ, Horton R, Sanchez JE, Hranitzky PM, Al-Ahmad A, Hao S, Hongo R, Beheiry S, Pelargonio G, Forleo G, Rossillo A, Themistoclakis S, Casella M, Russo AD, Tondo C, Dixit S. Pulmonary Vein Isolation to Reduce Future Risk of Atrial Fibrillation in Patients Undergoing Typical Flutter Ablation: Results from a Randomized Pilot Study (REDUCE AF). J Cardiovasc Electrophysiol. 2015 Aug; 26(8):819-825.
Score: 0.011
-
Mohanty S, Mohanty P, Rutledge JN, Di Biase L, Yan RX, Trivedi C, Santangeli P, Bai R, Cardinal D, Burkhardt JD, Gallinghouse JG, Horton R, Sanchez JE, Bailey S, Hranitzky PM, Zagrodzky J, Al-Ahmad A, Natale A. Effect of catheter ablation and periprocedural anticoagulation regimen on the clinical course of migraine in atrial fibrillation patients with or without pre-existent migraine: results from a prospective study. Circ Arrhythm Electrophysiol. 2015 Apr; 8(2):279-87.
Score: 0.011
-
Lewis RK, Pokorney SD, Greenfield RA, Hranitzky PM, Hegland DD, Schroder JN, Lin SS, Milano C, Daubert JP, Smith PK, Hurwitz LM, Piccini JP. Preprocedural ECG-gated computed tomography for prevention of complications during lead extraction. Pacing Clin Electrophysiol. 2014 Oct; 37(10):1297-305.
Score: 0.011
-
Bai R, DI Biase L, Valderrabano M, Lorgat F, Mlcochova H, Tilz R, Meyerfeldt U, Hranitzky PM, Wazni O, Kanagaratnam P, Doshi RN, Gibson D, Pisapia A, Mohanty P, Saliba W, Ouyang F, Kautzner J, Gallinghouse GJ, Natale A. Worldwide experience with the robotic navigation system in catheter ablation of atrial fibrillation: methodology, efficacy and safety. J Cardiovasc Electrophysiol. 2012 Aug; 23(8):820-6.
Score: 0.009
-
Sun AY, Koontz JI, Shah SH, Piccini JP, Nilsson KR, Craig D, Haynes C, Gregory SG, Hranitzky PM, Pitt GS. The S1103Y cardiac sodium channel variant is associated with implantable cardioverter-defibrillator events in blacks with heart failure and reduced ejection fraction. Circ Cardiovasc Genet. 2011 Apr; 4(2):163-8.
Score: 0.009
-
Atwater BD, Wallace TW, Kim HW, Hranitzky PM, Bahnson TD, Hegland DD, Daubert JP. Pulmonary vein contraction before and after radiofrequency ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2011 Feb; 22(2):169-74.
Score: 0.008
-
Atwater BD, Thompson VP, Vest RN, Shaw LK, Mazzei WR, Al-Khatib SM, Hranitzky PM, Bahnson TD, Velazquez EJ, Califf RM, Lee KL, Roe MT. Usefulness of the Duke Sudden Cardiac Death risk score for predicting sudden cardiac death in patients with angiographic (>75% narrowing) coronary artery disease. Am J Cardiol. 2009 Dec 15; 104(12):1624-30.
Score: 0.008
-
Singh JP, Rosenthal LS, Hranitzky PM, Berg KC, Mullin CM, Thackeray L, Kaplan A. Device diagnostics and long-term clinical outcome in patients receiving cardiac resynchronization therapy. Europace. 2009 Dec; 11(12):1647-53.
Score: 0.008
-
Piccini JP, Hranitzky PM, Kilaru R, Rouleau JL, White HD, Aylward PE, Van de Werf F, Solomon SD, Califf RM, Velazquez EJ. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry). Am J Cardiol. 2008 Dec 01; 102(11):1427-32.
Score: 0.007